{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"In patients with LPI values above threshold 0.5umol/L at baseline, number of patients had LPI suppressed below this value after treatment. Measurement of LPI is done on plasma specimens.","groups":[{"description":"Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.","id":"OG000","title":"Arm I"}],"populationDescription":"No patient had elevated LPI level above 0.5umol/L at baseline.","reportingStatus":"POSTED","timeFrame":"Assessed through 6 months from the start of treatment","title":"Number of Patients With LPI Below 0.5 Umol/L After Treatment","type":"SECONDARY"}